Who is sponsoring NCT04480203?

NCT04480203 is sponsored by Norwegian Institute of Public Health.

What drugs are being tested in NCT04480203?

Interventions in NCT04480203: Stressproffen cognitive based stress management, Stressproffen mindfulness based intervention, Control.

What condition does NCT04480203 study?

NCT04480203 studies Breast Cancer Patients, Health, Subjective.

Is NCT04480203 still recruiting?

NCT04480203 is currently recruiting now. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT04480203: CABC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Recruiting now NA Last updated 2 March 2022

What this trial tests

NA trial testing Stressproffen cognitive based stress management in Breast Cancer Patients in 390 participants. Currently enrolling.

Timeline

15 January 2021

Primary endpoint
31 August 2023

31 December 2035

Quick facts

Lead sponsor	Norwegian Institute of Public Health
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	390
Start date	15 January 2021
Primary completion	31 August 2023
Estimated completion	31 December 2035
Sites	1 location across Norway

Drugs / interventions tested

Stressproffen cognitive based stress management
Stressproffen mindfulness based intervention
Control

Conditions studied

Breast Cancer Patients — all drugs for Breast Cancer Patients →
Health, Subjective — all drugs for Health, Subjective →

Sponsor

Norwegian Institute of Public Health

Who can join

Adults 20 to 69, female only, with Breast Cancer Patients or Health, Subjective. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions.
Svendsen K, Nes LS, Meland A, Larsson IM, et al · · 2023 · cited 8× · PMID 37103493 · DOI 10.2196/47195
Testing two digital stress-management interventions in a randomized controlled trial of breast cancer patients.
Svendsen K, Nes LS, Leithe S, Meland A, et al · · 2025 · cited 1× · PMID 41198868 · DOI 10.1038/s41598-025-22889-0
Coping after breast cancer (CABC-trial): Testing two digital stress-management interventions in a randomized controlled trial at 6 months
Svendsen K, Nes LS, Leithe S, Meland A, et al · · 2024 · DOI 10.21203/rs.3.rs-4915515/v1

Verify or expand the search:

Other recruiting trials for Breast Cancer Patients

Currently open trials in the same condition.

NCT07041762 — Rhomboid Intercostal Block With Sub-Serratus Plane Block Versus Erector Spinae Block · NA · recruiting
NCT06964802 — The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy · NA · recruiting
NCT07037576 — Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosth · recruiting
NCT07253987 — Cancer Survivors Program · NA · recruiting
NCT06884852 — Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastect · NA · recruiting

Other Norwegian Institute of Public Health trials

Trials by the same sponsor.

NCT07442318 — Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia · NA · not yet recruiting
NCT07135115 — Targeting Lifestyle to Improve Colorectal Cancer Screening · NA · not yet recruiting
NCT07355569 — The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway · NA · completed
NCT06324409 — ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening · NA · completed
NCT06374316 — Air Purifiers in Classrooms for Infection Control - a Pilot Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04480203 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian Institute of Public Health
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04480203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing